a1Achy is one of the acute-phase proteins, which are mainly synthetized in the liver. Like C-reactive protein and serum amyloid A protein, a1Achy is one of the acute-phase reactantswhose concentration markedly increases within 12 h of tissue injury or infection (2,3). Moreover, aiAchy is known to inhibit chymotrypsin-like proteases (4-6) by formation of an equiinolar complex with these enzymes. The role of ajAchy in the modulation of the immune response has been shown recently: it inhibits the natural cytotoxic activity of T-cell killer lymphocytes and antibody-dependent cell-mediated cytotoxicity (7), and it enhances antibody response (8).
a1-Antichymotrypsin
(a1Achy) is a serum glycoprotein with 811 Mr of about 59 000. It has a carbohydrate content of 24% (1). Its concentration in the serum of healthy individualsranges from 200 to 600 mg/L (2). a1Achy is one of the acute-phase proteins, which are mainly synthetized in the liver. Like C-reactive protein and serum amyloid A protein, a1Achy is one of the acute-phase reactantswhose concentration markedly increases within 12 h of tissue injury or infection (2,3). Moreover, aiAchy is known to inhibit chymotrypsin-like proteases (4-6) by formation of an equiinolar complex with these enzymes. The role of ajAchy in the modulation of the immune response has been shown recently: it inhibits the natural cytotoxic activity of T-cell killer lymphocytes and antibody-dependent cell-mediated cytotoxicity (7), and it enhances antibody response (8).
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ReceivedDecember 15, 1987;acceptedFebruary 8, 1988. differences in carbohydrate structure, was demonstrated by means of crossedimmunoafllnoelectrophoresis (CIAE), with free lectin used in the first dimension (9) . Variations in the pattern of microheterogeneity of a1Achy and of some other glycoproteins have been detected in various diseases (10) (11) (12) (13) (14) . In previous studies (12, 14) a1Achy was shown to exhibit four peaks in CIAE. Until now, the relationship between the separation obtained in affinity chromatography on immobilized concanavalin A (Con A) and the pattern observed in CIAE has never been investigated. Here we report the separation of a1Achy into three microheterogeneous forms with distinct affinity for Con A. Furthermore, the aim of this study was to examine the changes of the a1Achy pattern on CIAE in sera from patients with various inflammatory syndromes, to determine if the changes were related to the origin of the inflammatory process. We studied three groups of patients: patients with acute inflammation, patients with chronic inflammation, and patients with chronic inflammation accompanied by acute attacks.
MaterIals and Methods
ajAchy from one healthy donor was purified by immunoaffinity chromatography as previously described (5) .
Specimens of normal (N) sera were obtainedfrom each of six healthy men and five healthy women, ages 22-67 y.
All the patients studied presented an acute-phase response (i.e., erythrocyte sedimentation rate and aglobulin concentration were above normal).
We studied three groups of patients. The first group included patients with acute inflammation: eight patients (six men and two women, ages 31-85 y) had recently (from three to nine days before)suffered an acute myocardial infarction (MO; 20 patients (18 men and two women, ages 20-65 y) developed septic inflammation (SI).
The second group consisted of patients with chronic inflammation: 12 women (ages 47-66 y) had breast cancer with metastases (MBC).
The 17 patients (10 men and seven women, ages 19-75 y) forming the third group had chronic inflammation accompanied by acute attacks; serum was sampled during an acute attack. These patients all developed a connective-tissue disease (CTh): there were two with systemic lupus erythematosus, two with rheumatoid arthritis, nine with temporal arteritis, and four with adult Still's disease (an inflammatory arthritis). The diagnoses were based on clinical, biological, radiological, or histological examination.
For some patients, blood was sampled at different intervals throughout the disease. None of the specimens were from individuals who were taking oral contraceptives.
All sera were promptly studied after centrifugation.
Antiserum against a1Achy was from Dako. Agarose (Indubiose A 45) and Con A were obtained from Industrie Biologique Fran#{231}aise. a-Methyl-n-glucoside was from Sigma Chemical Co., Sepharose 4 B from Pharmacia. For affinity chromatography we used a Con A-Sepharose 4 B column prepared in our laboratory: 100mg of Con A was coupled to 25 mL of Sepharose 4 B and affinity-chromatography experiments were performed according to Kerckaert and Bayard (16). The Con A-reactive material was desorbed by 0.2mol/L a-methyl-r-glucoside in the equilibration buffer. We collected 3.5-mL fractions and followed the course of the fractionation of a1Achy by electroimmunoassay on agarose plates containing specific antibodies againsta1Achy.
For CIAE we used a modification of the method of B$gHansen et al. (9), with 10 g/L agarose gels, 10 x 10 x 0.15 cm. Briefly, the procedure was as follows. Free Con A (250 ,u.g/cm2)was placed in a 1 x 8 cm trap gel in the first dimension. Three microliters of serum was applied for each analysis. The first dimension was run for 80 mm at 10 V/cm. The second dimension was run for 18 h at 2 V/cm in 10 g/L agarose gel, which was poured onto the upper two-thirds of the plate and which contained, per square centimeter, 0.3 1L of specific antiserum against a1Achy and a-methyl-nglucoside (200mg per 10.5 mL of agarose) (17) . Peak areas enclosedby precipitates were measured by weighing a paper tracing of each pattern. The different peaks were delimited by vertical lines, and their relative proportions were expressed as percentages of the whole precipitate area. We checked, with several sera, not only the within-run and within-day reproducibilities but also the day-to-day reproducibility.
For statistical evaluation we used the Mann-Whitney nonparameti-ic test.
Results
By affinity chromatography on the Con A-Sepharose 4 B column prepared in our laboratory we could resolve purified human a1Achy into three fractions (Figure la) . Con A-nonreactive fraction (A) and Con A-weakly reactive fraction (B) were eluted with the equilibration column buffer. The Con A-reactive fraction (C) was desorbed by addition of the glucoside to the same buffer.
Purified a1Achy, studied by CIAE (Figure lb) , was resolved into four peaks (peak 1, the most anodic, and peak 4, the most cathodic). As Figure lb shows, there was a good correlation between the chromatography elution profile and the peaks observed in CIAE: the Con A-nonreactive fraction corresponded to peak 1 in CIAE, the Con A-weakly reactive fraction to peak 2, and the Con A-reactive fraction to peaks 3 + 4. Peak 4 only became visible when a-methyl-nglucoside was added to the second-dimension gel. In fact, peak 3 corresponds to Con A-a1Achy complexes that were able to migrate in both dimensions. This four-peak a (Figure 2a ) and for the various pathological sera we studied (typical examples in Figure 2b-e) . We determined the relative proportions of peak 1, peak 2, and peaks 3+4 to obtain the distribution in each serum of the three a1Achy populations with distinct affinity forCon A.
The inflammatory sera showed higher peaks in CIAE, but this increase varied according to the patients' disorder ( Figure 2) ; the greatest increase was observed in peak 1 and peak2inCTDandinpeaks3 + 4inSI,whilepeaklwas decreased in SI when compared with N. In MI and MBC, the four peaks were increased. Table 1 gives a1Achy concentrations and the distribution of the three microheterogeneous forms in serum for the different groups. Table 2 summarizes the relative variations, as compared with N, of these three forms that we observed. The a1Achy concentration was significantly increased in all pathological sera. As compared with N and with MI, there was a decreased proportion of peak 1 and an increased proportion of peaks 3+4 in SI. In CTD there was an increased proportion of peak 1 and a decreased proportion of peaks 3 + 4 as compared with N. We noticed that, in SI, the variations were more pronounced in bacterial than in viral infection, whatever the severity of the illness, and that the greatest changes within the CTD group were in cases of temporal arteritis (compare Tables 1 and 3) . We saw no overlap between the proportionofCon A-nonreactive fraction (peak 1) found in the sera of the patients with CTD or with MBC and those with SI. Peak i in a proportion less than 17% was found in none of the sera from N or from patients with MI, MBC, or CTD but in 17 of the 20 sera from patients with SI (sensitivity 85%, specificity 100%). MI and SI differed significantly from N, and SI from ML No statistical difference was found in MBC as compared with N.
Especially interesting was the case of a 25-year-old woman who presented with systemic lupus erythemathaus, fever, process and who, before any treatment, displayed an ajAchy proffle in CIAE with 14.5% Con Anonreactive fraction, as we had observed in septic inflammation. At the same time, the diagnosis of septicemia was established on the basis of blood cultures. Thus we compared CFI) with SI, finding a highly significant difference for each of the three forms (as indicated in Table 1 ).
The sera from six patients with temporal arteritis and from four patients with bacterial infection were studied in CIAE at different intervals throughout their disease ( Table  3) . We observed a rapidchange of the a1Achy profile when a specific treatment was started while a1Achy concentrations in serum were still abnormally high. After one month of treatment with glucocorticoids in temporal arthritis and after 48 h of antibiotic treatment in bacterial infection, the relative proportions of the three forms evolved to those found in N. After six months of glucocorticoids in temporal arteritis these three forms were identical to N (result not shown) but the ajAchy concentration remained slightly high.
Discussion
Affinity chromatography of purified a1Achy on a column of Con A-Sepharose 4 B prepared in our laboratory separated this acute-phase reactant into three microheterogeneous forms. In fact, in CIAE, the human a1Achy, whether purified or in untreated serum, displayed four peaks. Peak 1 is the most anodic, peak 4 the most cathodic (addition of sugar to the second-dimension gel is needed to make peak 4 visible). Our results led us to conclude that Con A-nonreactive fraction on our own Con A-Sepharose 4 B column corresponded to peak 1, the weakly reactive fraction to peak 2, and the reactive fraction to peaks 3+4. Thus in all the studies that followed we expressed the relative proportions of these three microheterogeneous forms (peak 1, peak 2, peaks 3 + 4) as percentages of the total precipitate area.
Here we have examined aiAchy concentration in, and the a1Achy proffle obtained by CIAE for, sera from normal subjects and from patients with various inflammatory diseases. As expected, the total concentration of a1Achy was significantly increased in all inflammatory sera, by up to fivefold. We could distinguish three groups of inflammatory disorders: one with acute inflammation (MI and SO, another with chronic inflammation (MBC), and the third with chronic inflammation accompanied by acute attacks (CTD).
In agreement with the literature (10-14) , we found an increased proportion of Con A-reactive fraction in acute inflammation, but this was not found in chronic inflammation. Moreover, we found a decrease of this fraction in chronic inflammation with acute attacks. Nevertheless, we note two other interesting features. First, in inflammatory states, when the peak 1 (Con A-nonreactive fraction) is, under our experimental conditions, less than 17% (see Table  1 ), a septic origin may be suspected (the sensitivity is substantially high: 85%). The second feature applies to the CTD group: peak 1 (Con A-nonreactive fraction) is either identical to N or is markedly increased without distinction of etiology. One patient with temporal arthritis who was followed throughout the disease had an acute attack after a few months' treatment when the glucocorticoid dosage was decreased. The a1Achy profile showed the same increased proportion of peak 1 as that observed before any treatment. Therefore, an increase in peak 1 and the immunological disorder in CTh might be related.
The case of the patient with systemic lupus erythematosus shows that CIAE may afford a means of differentiating between an exacerbation of disease and a septic process favored by the immunodeficiency from the disease. It is well known that it is sometimes difficult, in systemic lupus erythematosus, to distinguish between an intercurrent infection and lupus activity in view of a biological inflammation.
The four cases of adult Still's disease (in the CPU group) provide another example in which CIAE may be of interest.
This disease sometimes looks like a septic pathology (with fever and an increase in the number ofpolymorphonuclear neutrophils in the blood). But all of our four patients with adult Stifi's disease had a Con A-nonreactive fraction (peak 1) constituting more than 17% of the total and were thus unlikely to have a septic pathology. Thus this test may be helpful for diagnosis and therapeutic purposes.
The changes observed in the repartition of the microheterogeneous forms in bacterial infection or in temporal arteritis are related to inflammation etiology, because when a specific treatment is used the changes gradually disappear. After six months of glucocorticoid treatment in temporal arteritis the a1Achy profile was identical to N. Thus the glucocorticoids do not affect the ajAchy profile. In fact, the origin of the changes in the repartition of the microheterogeneous forms of a1Achy observed is still not elucidated. The glycosylation or the clearance, or both, of the aiAchy forms might vary in inflammatory process according to its etiology. Boldt and Armstrong (18) suggested that the immunological function of the glycoproteins would be attributed to the highly branched N-glycan. In CPU the Con A-nonreactive fraction, which probably contains highly branched ajAchy, predominated.
The autoinmiune participation in these illnesses is well established. The structural data and the immunological function of each a1Achy microheterogeneons form have yet to be elucidated. Such experiments are now in progress.
Study of a1Achy microheterogeneity in CIAE may provide a useful test in the differential diagnosis in inflammatory syndromes. This test is easy to perform, rapid, inexpensive, and reliable, and it requires only a very small amount of serum. It helps guide the diagnosis when there is an increase of the erythrocyte sedimentation rate. Thus it may help the clinician in recognizing infection.
